Amgen Total Current Assets from 2010 to 2026

AMG Stock   311.30  1.10  0.35%   
Amgen Total Current Assets yearly trend continues to be comparatively stable with very little volatility. Total Current Assets will likely drop to about 24.3 B in 2026. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2019-03-31
Previous Quarter
26.7 B
Current Value
27.9 B
Quarterly Volatility
8.4 B
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 443.7 M, Interest Income of 218.9 M or Interest Expense of 3.8 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
The evolution of Total Current Assets for Amgen Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Amgen compares to historical norms and industry peers.

Latest Amgen's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Amgen Inc over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Amgen's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Amgen Total Current Assets Regression Statistics

Arithmetic Mean35,301,756,863
Geometric Mean33,302,396,704
Coefficient Of Variation33.12
Mean Deviation10,758,610,381
Median37,618,000,000
Standard Deviation11,693,572,404
Sample Variance136739635.6T
Range31B
R-Value(0.79)
Mean Square Error54214464.1T
R-Squared0.63
Significance0.0001
Slope(1,835,527,124)
Total Sum of Squares2187834169T

Amgen Total Current Assets History

202624.3 B
202526.1 B
202429 B
202330.3 B
202222.2 B
202119.4 B
202021.1 B

About Amgen Financial Statements

Amgen shareholders use historical fundamental indicators, such as Total Current Assets, to determine how well the company is positioned to perform in the future. Although Amgen investors may analyze each financial statement separately, they are all interrelated. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses on on Amgen's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets26.1 B24.3 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Amgen Stock Analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.